-
1550P Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence2024 Annals of Oncology article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, A. Huisman, Hans J.L. Timmer, L. Fagereng, Åslaug Helland, Bettina Ryll, +9 more
1citations -
1347P Peripheral osimertinib (osi) plasma trough concentration (Cmin,SS) as surrogate parameter for development and progression of brain metastasis (BM) in patients (pts) with EGFR+ advanced non-small cell lung cancer (aNSCLC)
Judith L. Gulikers, M.G.D. Veerman, M. Jebbink, Paul D. Kruithof, Christi M. J. Steendam, René J. Boosman, +9 more
0citations
5 results